Shares of Trinity Biotech climbed after the company released what it called compelling results from a study of its next-generation continuous glucose monitoring system, a device used for diabetes ...
Continuous glucose monitors provide diabetics with an invaluable data set for managing their blood sugar level. Right now, these wearable solutions still use a needle for access to your bloodstream.